A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C - Lindsay, Karen L.; Trepo, Christian; Heintges, Tobias; Shiffman, Mitchell L.; Gordon, Stuart C.; Hoefs, John C.; Schiff, Eugene R.; Goodman, Zachary D.; Laughlin, Mark; Yao, Ruji; Albrecht, Janice K. (Hepatology (Baltimore, Md.), 2001)
Keywords: Adult; Aged; Antiviral Agents - adverse effects; Antiviral Agents - therapeutic use; Biological and medical sciences; Digestive system; Double-Blind Method; Female; Hepacivirus - genetics; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - pathology; Hepatitis C, Chronic - virology; Humans; Interferon-alpha - adverse effects; Interferon-alpha - therapeutic use; Liver - pathology; Male; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Polyethylene Glycols; Recombinant Proteins; RNA, Viral - blood; Human; Alpha interferon; Cytokine; Hepatic disease; Induction treatment; Infection; Chronic; Randomization; Viral disease; Immunotherapy; Double blind study; Digestive diseases; Clinical trial; Viral hepatitis C